RIV Capital and Cansortium Debut MOODS Cannabis Line in NY
Exciting New Launch of MOODS Cannabis Products in New York
RIV Capital Inc. has partnered with Cansortium Inc. to introduce a vibrant and innovative cannabis brand called MOODS in the New York market. The company has made MOODS available in their Etain-branded dispensaries, alongside plans to expand availability through third-party dispensaries as wholesale sales kickoff.
Experience the Flavor and Effects of MOODS
MOODS is recognized as a flavor-driven brand focused on enhancing the user experience. Its product line features cannabis formulated with floral terpenes that promote rich flavors, allowing users to enjoy different effects ranging from uplifting joy to soothing relaxation. The brand offers four primary strains: Miami Vibes (Sativa), Kingdom Dreams (Indica), Golden Hour (Sativa), and Everglade Haze (Hybrid).
Product Offerings and Features
MOODS provides several consumption formats designed for diverse preferences. Some of the top-quality products include:
- MOODS Mini All-in-One: A compact, rechargeable vape device accommodating a full gram of cannabis, equipped with advanced technology for rich flavors.
- MOODS 0.5g Dash All-In-One: This sleek vape device operates at 3.5v with a rechargeable design, offering efficient and smooth vaping experiences.
- MOODS 1g Cartridges: These versatile cartridges combine traditional features with modern innovation, providing cannabis experiences rich in flavor.
Success in the Retail Market
The initial launch of MOODS in New York met an enthusiastic reception from consumers. According to Dave Vautrin, RIV Capital's Interim CEO, the product quickly became the top-selling vape brand across participating dispensaries by both revenue and volume during its debut month. This positive response reflects the brand's potential for substantial growth in the cannabis market.
Participation in the Revelry Cannabis Festival
In celebration of the MOODS launch, RIV Capital and Cansortium plan to showcase their products at the upcoming Revelry Cannabis Festival in New York. This two-day event will spotlight the fusion of cannabis and culture, featuring music performances, keynote discussions, and unique brand activations. Festival-goers will have the opportunity to explore the new line of MOODS products, solidifying the brand's footprint in New York.
About RIV Capital
RIV Capital is dedicated to forming a leading multistate platform in the cannabis sector, flaunting a strategic portfolio of brands across key U.S. markets. With expert knowledge and experience in the cannabis domain, the company is committed to expanding its brand presence and collaborating with established cannabis operators. The recent acquisition of Etain serves as a key component of its U.S. strategy.
Frequently Asked Questions
What is the MOODS cannabis brand?
MOODS is a cannabis brand launched by RIV Capital and Cansortium, emphasizing flavorful experiences with a range of products designed for effect-driven use.
Where can I buy MOODS products?
MOODS products are available at Etain-branded dispensaries in New York and will expand into other third-party dispensaries.
What strains does MOODS offer?
MOODS offers four core strains: Miami Vibes (Sativa), Kingdom Dreams (Indica), Golden Hour (Sativa), and Everglade Haze (Hybrid).
What makes MOODS different from other cannabis brands?
MOODS is designed to provide not just variety but also a unique tasting experience, enhanced with floral terpenes to elevate flavor and effects.
What events are RIV Capital and Cansortium participating in?
They will participate in the Revelry Cannabis Festival in New York, celebrating cannabis culture with a focus on the MOODS product line.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target
- Growth Forecast: Mainframe Spending and Cloud Strategies Explored
- Heitman LLC Expands Logistics Footprint with New Acquisition
- Deutsche Bank Lowers Boeing Price Target, Retains Buy Rating
- Larry Mazza Launches Exclusive Sports Betting Membership Site
- Glean and Algorithia Join Forces to Transform AI Workflows
- Onconetix Secures $2 Million Funding to Boost Oncology Innovations
- Dun & Bradstreet Prepares for Q3 Earnings and Investor Events
- Join Acclaimed Medium James Van Praagh for Spirit Messages
- Agora Unveils Innovative Voice-Driven AI SDK with OpenAI
Recent Articles
- Constellation Brands Shows Strong Growth in Fiscal Q2 Results
- Natural Grocers Unveils Autumnfest Super Savings Event
- Nano Dimension Shows Strong Q3 Growth Despite Industry Challenges
- RevitaLash® Cosmetics Celebrates 12 Years of Beauty Recognition
- Immix Biopharma's NEXICART-2 Trial: A New Horizon for CAR-T Therapy
- Millennials and Gen Z Transforming the Political Landscape
- Briacell Therapeutics Gains Traction with Promising Trial Results
- Nevada King Gold Corp Unveils New High-Potential Targets for Drilling
- Soligenix Partners with Sterling Pharma for Hypericin Production
- Deutsche Bank Boosts Crane's Price Target on Strong Earnings Outlook
- RIV Capital Partners with Cansortium for MOODS Brand Launch
- Positive Outlook for Lockheed Martin with Boosted Targets
- Advarra Expands Gene Therapy Network to 1,500 Sites Worldwide
- Deutsche Bank Boosts Allegheny Technologies Price Target
- Mizuho Upgrades RPM International: A Bright Future Ahead
- Major U.S. Firms Gear Up for Holiday Workforce Expansion
- Apple's App Store Revenue Growth Highlights Q4 Success
- Market Activity: Levi Strauss Drops While EQT Corporation Gains
- Revolutionizing EV Charging: AutoGreenCharge App Launches
- Market Movements: Insights on Tesla, Nike, and Humana Today
- Market Insights: Navigating S&P 500 Trends Amid Challenges
- Desktop Metal and Nano Dimension Merger Gets Stockholder Approval
- Global Aircraft Lighting Market Set for Significant Growth
- AI's Role in Transforming the Future of Packaging Solutions
- Growth Insights for Automotive Collision Repair Market 2034
- Exploring the Growth Potential of Check Point Software Technologies
- Refrigerated Transport Sector Anticipated to Hit $194.2 Bn
- Flow Capital Finalizes Legacy Investment with Strong Returns
- BridgeBio Reports Compelling ATTRibute-CM Study Results
- Elevai Labs Strengthens Patent Portfolio for EL-22 Therapy
- Legend Biotech Expands R&D With New Facility in Philadelphia
- Green Thumb Industries Announces Earnings Call for Third Quarter
- Class 1 Nickel Increases Resource Estimate for Dundonald Deposit
- Stingray Group Inc. Prepares for Upcoming Financial Results
- Plymouth Industrial REIT Showcases Q3 Progress and Developments
- Nano Dimension Reports Impressive Q3 Results with 21% Growth
- CytoMed Therapeutics Expands Cord Blood Asset Acquisition Strategy
- Carbon Done Right's Impactful Rewilding Efforts Expand in Miles
- Acadia Healthcare Investors Advised to Explore Legal Options
- Canada Carbon Launches Exciting Private Placement to Boost Growth
- Cleveland Cavaliers Enhance Security with Xtract One's Tech
- Alta Equipment Group Declares Attractive Preferred Stock Dividend
- Apollo Silver Corp. Secures Funding for Growth Initiatives
- McDermott Secures Key Contract for Major Offshore Pipeline Project
- McCoy Global Secures Major Contract for Smart Casing Technology
- MT Group Signs Major Contract for LNG Facility Construction
- Boardwalk REIT's Housing Demand Insights and Growth Plans
- Zevia Achieves Compliance with NYSE Listing Standards
- 1911 Gold Launches Extensive Drill Program at True North Mine
- Market Sentiment Steers Traders Amid Job Data Anticipation